All Stories

  1. Treatment of acromegaly increases BMD but reduces Trabecular Bone Score - a longitudinal study

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Ansgar Heck

  2. MR-undersøkelse predikerer behandlingsrespons ved akromegali

    Article • Tidsskrift for Den norske legeforening, January 2016, Norwegian Medical Association

    Ansgar Heck

  3. MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly

    Article • Endocrine, November 2015, Springer Science + Business Media

    Ansgar Heck

  4. Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2013, Endocrine Society

    Ansgar Heck

  5. Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery

    Article • PLoS ONE, June 2013, PLOS

    Ansgar Heck

  6. Intensity of pituitary adenoma on T2‐weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly

    Article • Clinical Endocrinology, June 2012, Wiley

    Ansgar Heck

  7. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

    Article • Clinical Endocrinology, December 2011, Wiley

    Ansgar Heck

  8. Photodynamische Therapie mit Photosan 3 und mikrosekunden Laserpulsen

    Article • January 1994, Springer Science + Business Media

    Ansgar Heck